According to a recent market study published by Growth Market Reports, titled, "Global Diagnostic Imaging Market by types, technologies, applications, end-users, and regions: Size, Share, Trends and Opportunity Analysis, 2017-2027", the market was valued at USD 47,132.7 Million in 2019 and is expected to grow at a rate of 6.6% by 2027. The global diagnostic imaging market is anticipated to grow significantly during the forecast period. Demand for diagnostic imaging is growing, due to increased demand for early disease diagnosis, broadening scope of medical applications, rapidly ageing population and the resulting rise in the prevalence of associated diseases, technological advancements in the diagnostic imaging industry, and incremental investments, funds, and grants by public-private organizations.

Request a free sample copy @ https://growthmarketreports.com/request-sample/2578

The global diagnostic imaging market has been fragmented based on products, applications, end-users, and regions. In terms of products, the global diagnostic imaging market is categorized as MRI systems, ultrasound imaging systems, CT scanners, nuclear imaging systems, X-Ray imaging systems, and mammography systems. The MRI systems segment is further sub-segmented into architecture (closed MRI systems and open MRI systems) and field strength (high and very-high field MRI systems, low-to-mid-field systems, and ultra-high-field systems).

The
ultrasound imaging systems segment is sub-segmented into technologies (2D ultrasound, 3D and 4D ultrasound, and doppler ultrasound) and portability (trolley/cart-based ultrasound systems and compact/portable ultrasound systems). The CT scanner segment is segregated further into conventional CT Scanners (high-slice CT scanners, mid-slice CT scanners, and low-slice CT scanners) and cone beam CT scanners. The nuclear imaging systems segment is further bifurcated into spect systems (Hybrid Spect Systems and Standalone Spect Systems) and hybrid PET systems. The X-Ray imaging systems segment is further categorized into types (digital x-ray imaging systems [direct radiography systems and computed radiography systems], analog x-ray imaging systems), and portability (stationary systems and portable systems). Based on applications, the market is classified as X-Ray imaging systems, MRI systems, ultrasound systems, CT scanners, nuclear imaging systems, and mammography systems. The X-Ray imaging systems segment is further segmented into general radiography, dental, and fluoroscopy.

The MRI systems is segregated into brain & neurological MRI, spine & musculoskeletal MRI, vascular MRI, pelvic & abdominal MRI, breast MRI, and cardiac MRI. The ultrasound system is categorized into radiology/general imaging, obstetrics/gynaecology (OB/GYN), cardiology, vascular, urology, and other applications. The CT scanners segment and the nuclear imaging systems segment both are further segregated into cardiology, oncology, neurology, and other applications.
On the basis of end-users, the market is segmented as hospitals, diagnostic imaging centres, and other end-users. Based on regions, the global diagnostic imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.


As per Growth Market Reports industry analyst, Divyanka Sankhe, “The diagnostic imaging market is driven by increasing demand for quick diagnosis of dreadful diseases such as cancer and coronavirus. The global burden of chronic diseases is increasing and medical imaging technologies are essential for accurate chronic disease diagnosis. Ageing population as well as changes in societal behavior are contributing to a continuous rise in prevalent and expensive long-term health issues. Cardiovascular illnesses, obesity, and diabetes account for the majority of mortalities caused by chronic diseases. According to the World Health Organization, the worldwide burden of chronic diseases is anticipated to reach 57% by 2020.”

The effect of COVID-19 pandemic situation led to the closure of several non-essential businesses, reducing the demand for industrial goods in the world, which in turn, is affecting several industries worldwide. Increasing R&D activities for developing new, cost-effective, and innovative products with antibodies are expected to fuel the market.

The recent outbreak of COVID-19 has a positive impact on the overall market, as various medical treatments for prevention of covid-19 infection are using diagnostic imaging. However, the growth of the healthcare industry is expected to decline by approximately 80% in 2020, due to the Covid-19 impact. The industry is expected to grow at 0.7% with revenue of approximately USD 2 tn in 2020. Procurement of capital equipment is projected to decline (revenue), due to the crisis, as elective procedures are kept on hold and delayed. Revenue from the medical devices industry is expected to be nearly US$ 370 billion in 2020, which was about USD 400 billion in 2019.

Key Takeaways from the Study

  • North America is expected to hold a significant share of the market, owing to early adoption of technologically advanced products for disease diagnostics in the region. It constituted 35.3% share of the market in 2020.
  • The X-Ray imaging systems segment is anticipated to grow significantly during the forecast period, due to increasing prevalence of orthopedic diseases. The segment accounted for 44.5% share of the market in terms of value in 2020.
  • In terms of value, the CT Scanners segment is expected to expand at a CAGR of 7.3% during the forecast period, owing to increasing penetration of CT scanners in developing countries.
  • In terms of value, the diagnostic imaging centres segment is expected to grow at a CAGR of 7.0% during the forecast period, owing to increasing investments and growing number of diagnostic centres globally.

Report Scope

Report Metric

Details

Market Value in 2019

USD 47,132.7 million

Market Growth Rate (from 2020 to 2027)

6.6%

Historical Data

2017 & 2018

Base Year

2019

Forecast Period

2020 – 2027

Market Segments

Products, Applications, End-users, and Regions

Scope

Global

Region Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Key Companies Profiled

Bruker
CANON MEDICAL SYSTEMS CORPORATION
Carestream Health
Cubresa Inc.
ESAOTE SPA
FUJIFILM Visualsonics, Inc.
GENERAL ELECTRIC COMPANY
Hitachi Healthcare Americas
Koninklijke Philips N.V.
Mediso Ltd.
MILabs B.V.
MR Solutions
PerkinElmer Inc.
Shimadzu Corporation
Siemens Healthineers AG

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Supply-side: Diagnostic imaging products manufacturers, raw material suppliers, primary respondents, and distributors.
  • Demand Side: Diagnostic Centers, Hospitals, Academic and Research Institutes, and others.
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: Food and Drug Administration (FDA), International Trade Centre (ITC), World Health Organization, Journal of Biomedical Science, Diseases Society of America, National Library of Medicine, and others.